跳至主要内容
临床试验/IRCT20230307057648N1
IRCT20230307057648N1尚未招募3 期

Evaluation of the effect of traditional Persian diabetes product (Tabashir tablet) on blood glucose level in patients with type 2 diabetes: a double-blind placebo-controlled clinical trial

Tehran University of Medical Sciences0 个研究点目标入组 106 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
入组人数
106

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 years 至 65 years(—)
性别
All

入选标准

  • •Uncontrolled type 2 diabetes
  • •Age 30-65 years
  • •HbA1c greater than 7 and lower than 8.5
  • •Under treatment with oral diabetes medications (one or more drug groups)
  • •At least one month after increasing the dose of antidiabetic medicine or prescribing a new antidiabetic medicine

排除标准

  • •Glomerular filtration rate, lower than 60 ml per minute
  • •Serum albumin, lower than 4 g/dL
  • •SGOT and SGPT, three times higher than normal level
  • •Pregnancy and breastfeeding or intention to become pregnant
  • •Taking insulin along with oral diabetes medications

研究者

相似试验